Completed
Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis
NCT05513014
- Conditions
- Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States